1. Home
  2. ALCO vs HUMA Comparison

ALCO vs HUMA Comparison

Compare ALCO & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alico Inc.

ALCO

Alico Inc.

HOLD

Current Price

$40.66

Market Cap

297.9M

Sector

N/A

ML Signal

HOLD

Logo Humacyte Inc.

HUMA

Humacyte Inc.

HOLD

Current Price

$0.93

Market Cap

308.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ALCO
HUMA
Founded
1960
2004
Country
United States
United States
Employees
N/A
184
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
297.9M
308.6M
IPO Year
1994
N/A

Fundamental Metrics

Financial Performance
Metric
ALCO
HUMA
Price
$40.66
$0.93
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
8
Target Price
$44.00
$6.19
AVG Volume (30 Days)
12.6K
8.3M
Earning Date
05-11-2026
05-15-2026
Dividend Yield
0.49%
N/A
EPS Growth
N/A
N/A
EPS
1.03
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$444.16
Revenue Next Year
N/A
$248.39
P/E Ratio
$39.17
N/A
Revenue Growth
N/A
N/A
52 Week Low
$31.11
$0.55
52 Week High
$45.01
$2.84

Technical Indicators

Market Signals
Indicator
ALCO
HUMA
Relative Strength Index (RSI) 44.72 38.35
Support Level $39.94 $0.89
Resistance Level $42.06 $1.28
Average True Range (ATR) 0.69 0.12
MACD -0.04 -0.06
Stochastic Oscillator 24.73 1.57

Price Performance

Historical Comparison
ALCO
HUMA

About ALCO Alico Inc.

Alico Inc is a Florida-based agribusiness and land management company that mainly focuses on citrus production and grove conservation. The company operates through two primary business units: Alico Citrus and Land Management and Other Operations. The Alico Citrus segment engages in the cultivation of citrus trees and delivers citrus to the processed and fresh citrus markets. It mainly serves the processed market and sells Hamlin oranges and the Valencia variety to the orange juice processors. The Land Management and Other Operations segment engages in land leasing for recreational, conservation, and mining activities. Alico Citrus delivers the majority of the revenue as the firm's primary operating business unit.

About HUMA Humacyte Inc.

Humacyte Inc is developing a commercial-stage biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.

Share on Social Networks: